https://www.avient.com/news/polyone-improves-driver-experience-new-onflex-lo-automotive-interiors
Notes to Editors: A 2012 study by the Ecology Center linked off gassing of automotive materials with health issues.
https://www.avient.com/news/polyone-hires-john-midea-senior-vice-president-global-operations-and-process-improvement
Midea will lead PolyOne’s award-winning global operational excellence initiatives, including manufacturing process improvement, environmental health and safety, global sourcing and logistics, Lean Six Sigma training and deployment, and integration of acquisitions.
https://www.avient.com/company/sustainability/sustainability-report/products/markets/healthcare-case-study
Plastics are a crucial tool in saving lives and improving health and safety in our communities.
https://www.avient.com/company/sustainability/people/community-service
Occupational Safety & Health
https://www.avient.com/company/policies-and-governance/avient-supplier-information
For training videos on how to create a Coupa Supplier account, how to view and manage your orders, how to create invoices from a purchase order and how to create catalogs, please visit this page.
How to e-invoice through Email (SAN)
Learn how to e-invoice through email (SAN).
https://www.avient.com/knowledge-base/article/accelerate-product-development-predictive-analytics
Learn more about how FEA can be applied to your application
Learn the basics of FEA: What it can do and how it helps
How it Helps
https://www.avient.com/knowledge-base/article/accelerate-product-development-predictive-analytics?rtype[]=1164
Learn more about how FEA can be applied to your application
Learn the basics of FEA: What it can do and how it helps
How it Helps
https://www.avient.com/news/polyone-announces-record-first-quarter-2014-results
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the final amount of charges resulting from the planned North American asset realignment and the Company's ability to realize anticipated savings and operational benefits from the asset realignment; our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
Special items include charges related to specific strategic initiatives or financial restructurings such as: consolidation of operations; debt extinguishment costs; employee separation costs resulting from personnel reduction programs, plant phase-out costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other postretirement benefit plans; environmental remediation costs, fines, penalties, remediation costs and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; unrealized gains and losses from foreign currency option contracts; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
Operating income at the segment level does not include: special items as defined on Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by chief operating decision makers.
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Antimony Trioxide.pdf
CATEGORY DETAIL
EC Number 215-175-0
CAS Number 1309-64-4
Name Subclass 1 Antimony Trioxide (ATO)
Structural Formula
CHEMICAL IDENTITY
PROPERTY DETAIL
Physical State Solid
Form Powder
Color White
Odor Odorless
Melting Point 656°C
Boiling Point 1425°C
Bulk Density 5.20 g/cm3
Water Solubility Slightly Soluble
PHYSICAL/
CHEMICAL
PROPERTIES
HEALTH EFFECTS
HUMAN HEALTH SAFETY ASSESSMENT
Consumer
It is very unlikely that consumers would be exposed to ATO in its concentrated
form because it is only sold for industrial use to make polymers and other products
and is not sold directly to consumers.
EXPOSURE
HUMAN HEALTH SAFETY ASSESSMENT
Human Health Consumers are not likely to be exposed to because it is not sold directly to
consumers nor are sales to consumer markets endorsed.
https://www.avient.com/sites/default/files/2020-10/demystifing-cmf-brochure.pdf
STANDING APART
FROM THE
COMPETITION
HOW DO MY CMF CHOICES SET ME APART
FROM COMPETITORS?
The ability to explore
multiple possibilities is how breakthroughs happen.
Predicting how design decisions will impact your operations
is essential.